位置:首页 > 产品库 > Atorvastatin hemicalcium trihydrate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Atorvastatin hemicalcium trihydrate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Atorvastatin hemicalcium trihydrate图片
CAS NO:344920-08-7
规格:≥98%

理化性质和储存条件

Molecular Formula: C33H35FN2O5.1/2Ca.3H2O;

Molecular Weight: 632.73


    In VitroAtorvastatin hemicalcium trihydrate treatment decreases apoptosis of myocardial cells by down-regulating GRP78, caspase-12 and CHOP expression in myocardial cells after myocardial infarction, and the endoplasmic reticulum (ER) stress is activated in response to heart failure and angiotensin II (Ang II) stimulation[4].
    In VivoAtorvastatin (20-30 mg/kg; oral gavage; once a day; for 28 days; ApoE–/– mice) hemicalcium trihydrate treatment significantly reduces endoplasmic reticulum (ER) stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in the Ang II-induced ApoE-/- mice. Proinflammatory cytokines such as IL-6, IL-8, IL-1β are all remarkably inhibited after Atorvastatin treatment[5]. Animal Model: Forty 8-week-old ApoE–/– mice induced with angiotensin II (Ang II)[5] Dosage: 20 mg/kg, 30 mg/kg Administration: Oral gavage; once a day; for 28 days Result: Significantly reduced ER stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in the Ang II-induced ApoE–/– mice. Proinflammatory cytokines such as IL-6, IL-8, IL-1β were all remarkably inhibited.
     
     
    维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025